Pyrazinamide
Pyrazinamide medicaments for therapeutic or prophylactic use
HSN 3004 20 93 (Pyrazinamide) is subject to Central Drugs Standard Control Organisation (CDSCO) import licensing and registration under the Drugs and Cosmetics Act, 1940. The Directorate General of Foreign Trade (DGFT) classifies this tariff line under the pharmaceutical import policy with mandatory e-Sanchit documentation requirements, including a Registration Certificate and Import Licence for drugs, verified at the bill of entry before out-of-charge.
- Registration certificate from CDSCO
- Import licence from CDSCO
- Certificate of Analysis from manufacturer
Procedural directions for customs clearance are issued by: Directorate General of Foreign Trade.
- 1Obtain a valid Registration Certificate for drugs (document code 101dc1) and an Import Licence for drugs (document code 9111dc) from CDSCO before filing the bill of entry. Both documents must be uploaded in e-Sanchit; customs will not grant out-of-charge until these are verified on PGA-facilitated bills.Drugs and Cosmetics Act, 1940 · document codes 101dc1 and 9111dc per CCR e-Sanchit requirement
- 2Upload in e-Sanchit the Certificate of Analysis for drugs (document code 0010dc), Batch Release Certificate (document code 0030dc), and Label of Consignment (document code 0110dc) before the bill of entry is presented for out-of-charge. All five mandatory document codes must be present for the consignment to clear.CCR e-Sanchit mandatory document codes 0010dc, 0030dc, 0110dc
The most common error on this tariff line is uploading the Registration Certificate while neglecting the Batch Release Certificate (0030dc) or the Label of Consignment (0110dc), treating them as secondary. All five document codes — 0010dc, 0030dc, 0110dc, 101dc1, and 9111dc — are individually mandatory; a consignment missing even one will be detained at the port of import, attracting demurrage and ground rent until the outstanding document is supplied or the consignment is directed for re-export.